Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
Clinical trial NCT07607587 · RECRUITING
Trial details
- NCT number
- NCT07607587
- Sponsor
- Novo Nordisk A/S
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-29
- Primary completion
- 2027-11-19
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.